Amir Weiss - 04 Mar 2026 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Chief Accounting Officer
Signature
/s/ Dov Bergwerk as attorney-in-fact for Amir Weiss
Issuer symbol
TEVA
Transactions as of
04 Mar 2026
Net transactions value
$0
Form type
4
Filing time
06 Mar 2026, 16:01:31 UTC
Previous filing
05 Mar 2026
Next filing
09 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Weiss Amir Chief Accounting Officer C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, ISRAEL /s/ Dov Bergwerk as attorney-in-fact for Amir Weiss 06 Mar 2026 0001897057

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +10,679 +99% 21,508 04 Mar 2026 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +5,650 +26% 27,158 04 Mar 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise -10,679 -100% $0.000000* 0 04 Mar 2026 Ordinary Shares 10,679 Direct F1, F2, F3
transaction TEVA Restricted Share Units Options Exercise -5,650 -33% $0.000000* 11,300 04 Mar 2026 Ordinary Shares 5,650 Direct F1, F2, F4
transaction TEVA Restricted Share Units Award +11,280 $0.000000* 11,280 04 Mar 2026 Ordinary Shares 11,280 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on March 4, 2022, with 10,676 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 10,679 vested on March 4, 2026.
F4 Restricted share units were granted on March 4, 2024, with 5,650 vested on each of March 4, 2025 and March 4, 2026, and 5,650 vesting on each of March 4, 2027 and March 4, 2028.
F5 Restricted share units were granted on March 4, 2026, with 2,820 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030.